Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors, now make this therapy available to older people; however,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Imus, Philip H., Tsai, Hua-Ling, Luznik, Leo, Fuchs, Ephraim J., Huff, Carol Ann, Gladstone, Douglas E., Lowery, Patrick, Ambinder, Richard F., Borrello, Ivan M., Swinnen, Lode J., Wagner-Johnston, Nina, Gocke, Christian B., Ali, Syed Abbas, Bolaños-Meade, F. Javier, Varadhan, Ravi, Jones, Richard J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737415/
https://ncbi.nlm.nih.gov/pubmed/31492679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados